In the pharmaceutical industry, regulatory compliance is not optional but it is the foundation of trust, product safety and patient health. Global regulatory standards are strict but still many pharmaceutical companies have faced serious regulatory actions for noncompliance. These issues not only cause financial losses but also damage the reputation of manufacturing company.

Analyzing the real world issues of non-compliances provides valuable information about what went wrong and how to prevent similar issues in future. In this post we will explore major regulatory failures and the lessons learned from these issues to understand how pharmaceutical manufacturers can strengthen their compliance

culture.

The ultimate intent of manufacturing in the pharmaceutical industry is to produce safe and effective medicines that are appropriate for patients, as well as having met all regulatory and legal requirements. While pharmaceutical products are known to fail at times, even though they may have been manufactured according to GMP quality systems, there continues to be an ongoing problem within the industry concerning failure of pharmaceutical

The recall was triggered after a potential packaging error at the manufacturing site, where two different antihypertensive medicines were incorrectly packaged. Crescent Pharma described the action as a “precautionary measure.” The issue came to light after a pharmacy complaint, when a patient reported that a pack labelled ramipril 5 mg capsules contained blister strips of amlodipine 5 mg tablets inside the sealed carton. 

Crescent Pharma is recalling batch GR164099 of Ramipril 5mg Capsules after packs were found to contain Amlodipine tablets instead due to a packaging error

Pharmaceutical Serialization And Aggregation Solution Refers To A System Used In The Pharmaceutical Industry To Uniquely Identify And Track Each Unit Of A Drug Or Pharmaceutical Product Throughout Its Lifecycle, From Manufacturing To Distribution, And Ultimately To The Patient. Serialization Involves Assigning A Unique Identifier (Serial Number) To Each Product Unit, While Aggregation Refers To The Process Of Linking Individual Product Units (E.g., Bottles Or Cartons) To Their Higher-Level Packaging (E.g., Pallets Or Cases).

Discover how artificial intelligence improves visual inspection accuracy, consistency and compliance in pharmaceutical manufacturing.

Agentic artificial intelligence (AI) gains popularity swiftly. This technology refers to AI systems designed to act autonomously towards specific goals. Agentic AI can plan, decide, take actions, and use tools without constant human prompting. Its goal-oriented behavior and decision-making capabilities make it valuable in different industries, involving healthcare. In this blog, we explore agentic AI in healthcare by focusing on real-world use cases. 

RFID ‌for Pharmaceuticals is a term used to describe the application of Radio Frequency Identification technology in monitoring, identifying, and handling pharmaceutical products at any given moment. RFID employs tags that are loaded with electronic data, readers, and software platforms for the automatic capturing and sharing of information without human intervention.
In contrast to conventional barcode systems, RFID eliminates the need for line-of-sight scanning and can identify several items at once. Therefore, it is perfectly suitable for pharmaceutical settings where precision, quickness, and data validity are of prime ​‍​‌‍​‍‌importance.

En pratique, ces QR codes frauduleux se nichent un peu partout : e-mails, documents numériques ou supports imprimés. Ils poussent insidieusement leurs victimes à délaisser les environnements sécurisés de leur entreprise au profit de terminaux personnels, souvent bien moins protégés. Un simple scan conduit vers de fausses pages imitant habilement des plateformes cloud ou des accès VPN. Le but ? Dérober des identifiants, contourner l’authentification multifacteur (MFA), puis ouvrir la porte à d’autres intrusions.

Built on an innovative, patent-pending antenna architecture, LiquidMate O delivers reliable direct-on-vial RFID tagging for liquid-filled injectable medications, an application long considered one of the most technically challenging in RFID deployment. Ineffective tracking of injectable drugs continues to drive substantial losses through expired inventory, misplaced medications, and regulatory exposure—particularly for high-value or critical products. As enforcement of the U.S. Drug Supply Chain Security Act (DSCSA) accelerates, dependable, high-accuracy RFID-based medication tracking has become essential to both pharmaceutical manufacturing and hospital operations.

Let's be honest—QR codes are underutilized. We've built this remarkable global infrastructure for machine-readable symbols, with error correction baked right into the standard, and we use them almost exclusively as glorified hyperlinks. QPI v1 asked the provocative question: "What if the QR code wasn't a link, but the data itself?" This paper takes that question and runs with it, addressing every practical limitation head-on.

Des équipements de production aux solutions de conditionnement et d’étiquetage, des systèmes d’administration de médicaments aux services CDMO, chaque zone d’excellence proposée par le salon Pharmapack illustre une même réalité : la chaîne de valeur pharmaceutique n’est plus fragmentée, mais interconnectée, collaborative et orientée vers la performance globale. L’innovation ne se limite plus à la molécule. Elle s’exprime désormais à chaque étape du cycle de vie.

Electronic consent systems hold significant promise for improving the informed consent process, particularly in rare disease research. By making the process more accessible, transparent, and user-friendly, eConsent platforms can enhance participant understanding, encourage data sharing, and streamline administrative tasks. The recommendations discussed, i.e. enhancing usability, improving communication, and strengthening data accuracy, are essential steps in ensuring that the consent process is ethical, robust and effective.

RFID in Pharmaceuticals Market is anticipated to expand from $3.2 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of approximately 11.8%. This rapid growth reflects the increasing adoption of Radio Frequency Identification (RFID) technology to enhance tracking, authentication, and management of pharmaceutical products.

From sourcing active pharmaceutical ingredients (APIs) and managing strict cold-chain protocols to navigating evolving regulatory landscapes, the sector faces mounting pressure from internal inefficiencies and external disruptions. Recent years have amplified these challenges, exposing vulnerabilities that threaten both operational continuity and patient outcomes.

The pharmaceutical industry is in a constant state of evolution, driven by technological advancements that are redefining everything from drug discovery to patient care. One of the most significant shifts is happening in a once-overlooked area: packaging. Far from being just a container, pharmaceutical packaging is now a critical component of the digital health ecosystem, offering unprecedented levels of safety, data, and efficiency.
Smart packaging is at the forefront of this transformation. By integrating digital technologies into traditional packaging formats, companies are unlocking new capabilities that enhance product integrity, improve supply chain visibility, and strengthen regulatory compliance. This article explores the current innovations in smart packaging and examines the operational and strategic benefits for pharmaceutical companies.

Sustainability in retail is no longer a moral side-note it’s becoming a core expectation. From packaging and supply chains to customer communication, brands are under pressure to eliminate waste, increase transparency and create more responsible experiences. Yet many of the solutions that promise sustainability often demand expensive tools, new systems or major operational changes.